WHO ICTRP trial

Comparison of safety and efficacy of propofol/fentanyl in pediatrics emergency…

IRCT20250525065887N1 · Iranian Registry of Clinical Trials (IRCT) · Recruiting

Key facts

Trial ID IRCT20250525065887N1
Public title Comparison of safety and efficacy of propofol/fentanyl in pediatrics emergency department
Scientific title Comparison of safety and efficacy of propofol/fentanyl and midazolam/fentanyl for procedural sedation
Primary sponsor Shahid Beheshti University of Medical Sciences
Registry Iranian Registry of Clinical Trials (IRCT)
Recruitment status Recruiting
Study type interventional
Phase 2
Countries Iran (Islamic Republic of)
Conditions Condition 1: Patients requiring LP. Condition 2: Patients requiring intubation. Condition 3: Patients with limb dislocation or fracture. Other reaction to spinal and lumbar puncture Respiratory disorder, unspecified Dislocation, sprain and…
Interventions Intervention 1: Intervention group: In the first intervention group, intravenous fentanyl (1–2 micrograms per kilogram) will be administered first, followed by slow intravenous administration of propofol (1–2 milligrams per kilogram). If…
Registration date May 28, 2025
Target size 84
Registry page irct.behdasht.gov.ir

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations